Clinical Trials Arena’s Post

Congresses are one of the best places to effectively engage KOLs and advance clinical decision making. I share a few strategies in @PharmExec with insight from other industry experts on how medical teams can maximize their impact at these events: https://lnkd.in/eSKBFaCT

Patients want to be heard! New research reveals a 28% decline in the perception of the pharmaceutical industry among patient groups in Ireland. Get the full story & how to bridge the gap in this week's Pharma Life Science newsletter. Read more here: pharmalifescience.com 👉Subscribe now and be part of the conversation. https://lnkd.in/gXKiKvaA #PharmaLifeScience

Patients want to be heard! New research reveals a 28% decline in the perception of the pharmaceutical industry among patient groups in Ireland. Get the full story & how to bridge the gap in this week's Pharma Life Science newsletter. Read more here: pharmalifescience.com 👉Subscribe now and be part of the conversation. https://lnkd.in/gXKiKvaA #PharmaLifeScience

Industry News Alert! 📰📢 The European pharmaceutical industry is calling for a competitive strategy and a dedicated office for life sciences to drive innovation and growth. Read more about this important push and its potential impact on the life science industry. Read the full article here - https://lnkd.in/ezz5mk2E #LifeSciences #PharmaceuticalIndustry #Innovation #IndustryNews #EFPIA

The process of bringing new drugs to market plays a crucial role in improving patient outcomes and advancing medical science. The United States, home to one of the world’s most rigorous regulatory systems for pharmaceuticals, has been making strides in accelerating drug approvals without compromising safety and efficacy. This article delves into the intricacies of the drug approval process in the US, exploring recent initiatives, challenges, and the potential impact on patients and the pharmaceutical industry. https://lnkd.in/dKgARhUu

What’s next for DCTs? In a recent Pharmaceutical Executive article we share insights on the evolution of this patient centric model and how to maximise the benefits DCTs bring to clinical research with the right processes and tools in place. https://ow.ly/RMM750RJAwg

Join us on Wednesday, Feb. 7 at noon to learn about our MS in Pharmaceutical Sciences program. The virtual information session will include a brief overview of the program, the application process, and time for questions. https://bit.ly/MSinPSCFeb7 #PharmaceuticalScience

The process of bringing new drugs to market plays a crucial role in improving patient outcomes and advancing medical science. The United States, home to one of the world’s most rigorous regulatory systems for pharmaceuticals, has been making strides in accelerating drug approvals without compromising safety and efficacy. This article delves into the intricacies of the drug approval process in the US, exploring recent initiatives, challenges, and the potential impact on patients and the pharmaceutical industry. https://lnkd.in/dKgARhUu

Rethinking the pharma R&D lifecycle with AI in mind Ashu Singhal and Sajith Wickramasekara, co-founders of Benchling, explore how AI's true promise for the pharmaceutical industry can only be realised if the entire pharmaceutical R&D lifecycle is supported. https://lnkd.in/gfVw8RSb #Pharma #ArtificialIntelligence #DrugDiscovery

What are the most common pitfalls in pharmaceutical R&D – and how do you avoid them? In the fast-paced world of pharmaceutical research and development, R&D departments face numerous challenges. From complex regulatory requirements to tight timelines, navigating the path to successful drug development can be difficult. Swipe through this article where Christine Weber, Principal Scientific Consultant, and Sanne Valentin, CMC Advisor, share their CMC expertise to help you navigate common challenges and show you how to steer clear of them. Which one of our 8 listed pitfalls do you consider the most challenging? #ResearchAndDevelopment #CMC #Pharma